Plethora Solutions Holdings Plc Share News (PLE)

Plethora Solutions Holdings Plc Information

There is currently no data for PLE

Plethora Says Fortacin Prescription Sales May Hit USD1 Billion A Year

Tue, 11th Nov 2014 10:48

LONDON (Alliance News) - Plethora Solutions Holdings PLC said Tuesday that peak prescription sales of its topical spray for the treatment of premature ejaculation Fortacin could reach over USD1 billion a year.

The company expects to present this data to shareholders and potential investors at its US investor road-show in New York and Boston during the week.

Other data Plethora will present will include the potential pricing or Fortacin, showing it expects a fairly wide variance in pricing in the EU and US, with prices in the US expects to be lower than in the US.

The price per does is expected to be between USD6 to USD10 in the EU, and around USD17 per does in the US.

It also plans to clarify and confirm the time-lines expected for the new drug application filing and potential approval of the product in the US. It expects to complete filing of the new drug application including the new can size in the fourth quarter of 2015 or first quarter of 2016. Following filing, it expects a 10 month prescription drug user fee act review, with commercial launch in the US expected for 2017.

Shares in Plethora are trading down 5.5% at 6.50 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

More News

13 Jul 2010 07:28

Plethora Solutions Sees 1H In Line With Market Views, Revenue GBP1M

LONDON (Dow Jones)--Plethora Solutions Holdings PLC (PLE.LN), the U.K.-based specialty pharmaceutical company, said Tuesday first half earnings are expected to be in line with analyst expectations with revenue for the six months ended June 30 of GBP1.0 million and of GBP1.4 million. MAIN FACTS:

30 Jun 2010 09:30

UK SMALLCAP ROUNDUP: Scott Wilson Bidder URS Gets Deadline

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps SCOTT WILSON GROUP PLC (SWG.LN), a U.K. engineering consultant, Wednesday said its board will give its recommendation to shareholders on the company's bi

30 Jun 2010 07:48

Plethora Solutions Gets GBP1 Mln Loan For Urology Business

LONDON (Dow Jones)--Drug company Plethora Solutions Holdings PLC (PLE.LN) Wednesday said it has agreed a GBP1 million, five-year secured term loan from a government fund which will be used to speed the roll-out of its specialty pharmaceutical business. The firm said The Urology Company, which it

5 May 2010 12:52

Small caps round-up: Global Brands, Japan Leisure, Plethora...

Shares in Global Brands charged forward as the Domino's Pizza franchise holder in Switzerland reported strong trading in 2010 to follow a good end to 2009. Global says January sales increased 7.4% on January 2009, February sales increased 11.2%, March sales increased 14.5% and April sales increased

9 Mar 2010 09:51

Small caps round-up: Ark Therapies, Pangea, Shore Capital ...

Shares in Ark Therapies fell back after the drug developer said it would consider approaches it has received following a recommendation that a further clinical trial would be needed before its brain cancer treatment Cerepro could be approved. Shares in Pangea Diamonds sparkled after the diamond pro

30 Nov 2009 07:37

Small caps round-up: SDI Group, First Property, Beowulf...

SDI swung into the black at the half-way stage, although the automated warehousing systems firm said the outlook remains "tough". There was a profit of £305,000 in the six months to 30 September versus a loss of £2.6m in the half year to 31 May 2008 (the year end has now moved from November to Marc

23 Nov 2009 13:17

Small cap round-up: Entertainment One, Plethora, Goldstone...

Film distributor Entertainment One reports record takings for the UK and Canadian opening of The Twilight Saga: New Moon, the sequel to the 2008 box office hit Twilight. New Moon, a film about vampires, has already generated an estimated weekend box office of more than £11m in the UK and $11m in C

17 Sep 2009 08:39

Small caps round-up: Byotrol, ReNeuron, Accuma...

Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30 to be ahead of expectations. Shares in Meridian Petroleum gushed higher after the oil and gas firm announced an increase in prospective resources in

29 Jul 2009 08:15

Plethora reports PSD502 trial success

Plethora Solutions has moved closer to global approval for its PSD502 premature ejaculation treatment for men after a final US phase 3 trial met all of its objectives. This study, involving patients from the US, Canada and Europe, was one of two pivotal Phase III studies for PSD502, which were run

26 May 2009 07:57

Plethora sells rights to key product

Drug developer Plethora has sold the rights of its key PSD502 premature ejaculation product to Sciele Pharma to cut its debts and pay back venture capital financing. Under the terms of the agreement, Sciele will make additional upfront payments of $8.4m and also share development costs for PSD502 f

Latest Share Chat

Plethora Solutions Holdings Plc Share News (PLE)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Plethora Says Fortacin Prescription Sales May Hit USD1 Billion A Year

Login to your account

Quickpicks are a member only feature

Login to your account